Mirae Asset Global Investments
IHE icon

Mirae Asset Global Investments’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Mirae Asset Global Investments’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8M Buy
+190,000
New +$17.1M 0.03% 318

Other funds holding IHE

IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $497M AUM 52.58% 1-Year Est. Return
AWM
Accurate Wealth Management Wesley Chapel, Florida $1.05B AUM 30.92% 1-Year Est. Return
FP
FFG Partners Fort Lauderdale, Florida $352M AUM 70.53% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
AFG
Arkansas Financial Group Little Rock, Arkansas $768M AUM 16.55% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
HCMT
Highland Capital Management (Tennessee) Memphis, Tennessee $2.17B AUM 54.74% 1-Year Est. Return
SIA
SeaBridge Investment Advisors Summit, New Jersey $692M AUM 52.26% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Mirae Asset Global Investments's IHE Position: Q2 2026 in Review

Mirae Asset Global Investments opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 190,000 shares worth $18.8M. The stake represents 0.03% of the portfolio and ranks #318 among its holdings.

50 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • Mirae Asset Global Investments held 190,000 shares of iShares US Pharmaceuticals ETF worth $18.8M as of Q2 2026.
  • iShares US Pharmaceuticals ETF was a new Mirae Asset Global Investments position in Q2 2026.
  • iShares US Pharmaceuticals ETF made up 0.03% of Mirae Asset Global Investments's portfolio in Q2 2026, its #318 holding.
  • 50 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.